Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ï¿¥195,273.2, with a 24-hour trading volume of ï¿¥0. The asset's market cap is ï¿¥174.13T, after moving -0.17% in the last day.
Tokenized Eli Lilly And Co is trading at ï¿¥195,984.73, with a tokenized market cap of ï¿¥7.6B and a 24-hour trading volume of ï¿¥333.89M. The tokenized asset has moved 0.86% in the past 24 hours.